Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2015

3 Dec 2015
Potential Eradication of HIV Reservoirs Data Published
26 Nov 2015
Grant of Options and Appendices 3B and 3Y
25 Nov 2015
Results of Annual General Meeting
24 Nov 2015
Presentation to Annual General Meeting
21 Oct 2015
Annual Report and Notice of AGM
15 Oct 2015
Appendix 3Y – Change of Director’s Interest Notice
6 Oct 2015
Presentation to Investors
6 Oct 2015
Letter to Shareholders
30 Sep 2015
Interim Data from BIT225-008 Study in Subjects with Hepatitis C Virus Genotype 3
28 Aug 2015
Year End Accounts and Preliminary Final Report
20 Aug 2015
Investor Presentation
28 Jul 2015
Shareholder Update
27 Jul 2015
Quarterly Cash Flow Report
15 Jul 2015
Share Purchase Plan Completed
6 Jul 2015
Independent Review of BIT225 Trial Data Supports Development in Combination with New HCV Drugs
3 Jul 2015
Appendix 3B
23 Jun 2015
Appendix 3B
18 Jun 2015
Biotron Share Purchase Plan and Placement to Raise $4.0 Million
16 Jun 2015
Request for Trading Halt
29 May 2015
Broker Meets Biotech 2015 Presentation
24 Apr 2015
Quarterly Report 31 March 2015
21 Apr 2015
R&D Tax Incentive
17 Apr 2015
Update on Phase 2 Trial and IND Progress
5 Mar 2015
Change of Director’s Interest Notice
2 Mar 2015
New Issue Announcement
27 Feb 2015
Half-year report 31 December 2014
26 Feb 2015
Response to ASX Compliance Letter
13 Jan 2015
Biotron Limited Presents at Biotech Showcase 2015
13 Jan 2015
Biotech Showcase 2015 Presentation
8 Jan 2015
Response to ASX Price Query

<<
2024

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 6 September 2024 Legal Notices and Privacy